Shares of ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report) traded up 0.8% on Monday . The company traded as high as C$6.70 and last traded at C$6.50. 19,980 shares were traded during trading, an increase of 3% from the average session volume of 19,376 shares. The stock had previously closed at C$6.45.
ImmunoPrecise Antibodies Trading Up 0.8 %
The company has a debt-to-equity ratio of 1.70, a quick ratio of 4.29 and a current ratio of 5.06. The stock has a market capitalization of C$162.08 million and a PE ratio of -7.30. The stock has a 50-day moving average price of C$6.50 and a two-hundred day moving average price of C$6.50.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
Featured Stories
- Five stocks we like better than ImmunoPrecise Antibodies
- How to Calculate Options Profits
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Do ETFs Pay Dividends? What You Need to Know
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
